These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32550806)

  • 1. Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach.
    Jaydip B; Dhaval M; Soniwala MM; Chavda J
    Saudi Pharm J; 2020 Jun; 28(6):737-745. PubMed ID: 32550806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
    Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
    Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study.
    Jhaveri M; Nair AB; Shah J; Jacob S; Patel V; Mehta T
    Drug Deliv Transl Res; 2020 Aug; 10(4):975-985. PubMed ID: 32124413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
    Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
    Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
    Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
    J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
    Venkateswarlu K; Preethi JK; Chandrasekhar KB
    Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
    Kapure VJ; Pande VV; Deshmukh PK
    J Pharm (Cairo); 2013; 2013():315902. PubMed ID: 26555972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Characterization of Liquisolid Tablets Based on Mesoporous Clays or Silicas for Improving Glyburide Dissolution.
    Cirri M; Mura P; Valleri M; Brunetti L
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32492869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier.
    Vraníková B; Svačinová P; Marushka J; Brokešová J; Holas O; Tebbens JD; Šklubalová Z
    Eur J Pharm Sci; 2021 Oct; 165():105952. PubMed ID: 34298140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
    El-Hammadi M; Awad N
    AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.